Phosphoramidate Prodrugs Continue to Deliver: The Journey of Remdesivir (GS-5734) from the Liver to Peripheral Blood Mononuclear Cells

Overview

Journal ACS Med Chem Lett

Publisher American Chemical Society

Specialty Chemistry

Date 2022 Apr 22

PMID 35450350

Authors

Victoria C Yan

Affiliations

Soon will be listed here.

Abstract

Remdesivir (GS-5734) is a monophenol, 2-ethylbutylalanine phosphoramidate prodrug of GS-441524 that is FDA-approved for the treatment of patients hospitalized for COVID-19. Despite showing strong, broad-spectrum antiviral activity in preclinical models, the clinical efficacy of remdesivir is mixed. This work highlights the pharmacodynamic discordance of remdesivir between humans and non-human primates, thereby demonstrating that non-human primate disease models overestimate the therapeutic efficacy of phosphoramidate prodrugs.

Citing Articles

Clinical pharmacodynamics of obeldesivir versus remdesivir.

Faghihi I, Yan V Antimicrob Agents Chemother. 2024; 68(9):e0096924.

PMID: 39133123 PMC: 11373207. DOI: 10.1128/aac.00969-24.

Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry.

Schimmel J, Epperson L, Aldy K, Wax P, Brent J, Buchanan J Drugs. 2024; 84(2):209-217.

PMID: 38198063 DOI: 10.1007/s40265-023-01981-7.

References

Pedersen N, Perron M, Bannasch M, Montgomery E, Murakami E, Liepnieks M . Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg. 2019; 21(4):271-281. PMC: 6435921. DOI: 10.1177/1098612X19825701. View

Pan H, Peto R, Henao-Restrepo A, Preziosi M, Sathiyamoorthy V, Abdool Karim Q . Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2020; 384(6):497-511. PMC: 7727327. DOI: 10.1056/NEJMoa2023184. View

Wang A, Hagen N, Padilha E, Yang M, Shah P, Chen C . Preclinical Pharmacokinetics and Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment. Front Pharmacol. 2022; 13:918083. PMC: 9424906. DOI: 10.3389/fphar.2022.918083. View

Speranza E, Williamson B, Feldmann F, Sturdevant G, Perez-Perez L, Meade-White K . Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med. 2021; 13(578). PMC: 7875333. DOI: 10.1126/scitranslmed.abe8146. View

Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y . Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236):1569-1578. PMC: 7190303. DOI: 10.1016/S0140-6736(20)31022-9. View

Mackman R, Hui H, Perron M, Murakami E, Palmiotti C, Lee G . Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine -Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV. J Med Chem. 2021; 64(8):5001-5017. DOI: 10.1021/acs.jmedchem.1c00071. View

Gottlieb R, Vaca C, Paredes R, Mera J, Webb B, Perez G . Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N Engl J Med. 2021; 386(4):305-315. PMC: 8757570. DOI: 10.1056/NEJMoa2116846. View

Crapo J, Barry B, Gehr P, Bachofen M, Weibel E . Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982; 125(6):740-5. DOI: 10.1164/arrd.1982.125.6.740. View

Dickinson P, Bannasch M, Thomasy S, Murthy V, Vernau K, Liepnieks M . Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis. J Vet Intern Med. 2020; 34(4):1587-1593. PMC: 7379040. DOI: 10.1111/jvim.15780. View

10.

Wang T, Babusis D, Park Y, Niu C, Kim C, Zhao X . Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir. Drug Metab Pharmacokinet. 2020; 35(3):334-340. DOI: 10.1016/j.dmpk.2020.04.333. View

11.

Yan V, Muller F . Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment. ACS Med Chem Lett. 2020; 11(7):1361-1366. PMC: 7315846. DOI: 10.1021/acsmedchemlett.0c00316. View

12.

Williamson B, Feldmann F, Schwarz B, Meade-White K, Porter D, Schulz J . Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020; 585(7824):273-276. PMC: 7486271. DOI: 10.1038/s41586-020-2423-5. View

13.

Ohl M, Miller D, Lund B, Kobayashi T, Miell K, Beck B . Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19. JAMA Netw Open. 2021; 4(7):e2114741. PMC: 8283561. DOI: 10.1001/jamanetworkopen.2021.14741. View

14.

Yan V, Muller F . Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola. Antimicrob Agents Chemother. 2021; 65(10):e0111721. PMC: 8448091. DOI: 10.1128/AAC.01117-21. View

15.

Mulangu S, Dodd L, Davey Jr R, Mbaya O, Proschan M, Mukadi D . A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med. 2019; 381(24):2293-2303. PMC: 10680050. DOI: 10.1056/NEJMoa1910993. View

16.

Li Y, Cao L, Li G, Cong F, Li Y, Sun J . Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models. J Med Chem. 2021; 65(4):2785-2793. DOI: 10.1021/acs.jmedchem.0c01929. View

17.

Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier F . Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ. 2022; 194(7):E242-E251. PMC: 8863204. DOI: 10.1503/cmaj.211698. View

18.

Humeniuk R, Mathias A, Cao H, Osinusi A, Shen G, Chng E . Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects. Clin Transl Sci. 2020; 13(5):896-906. PMC: 7361781. DOI: 10.1111/cts.12840. View

19.

Warren T, Jordan R, Lo M, Ray A, Mackman R, Soloveva V . Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016; 531(7594):381-5. PMC: 5551389. DOI: 10.1038/nature17180. View

20.

Sofia M, Bao D, Chang W, Du J, Nagarathnam D, Rachakonda S . Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J Med Chem. 2010; 53(19):7202-18. DOI: 10.1021/jm100863x. View